喘息・COPD治療薬の世界市場は、2022年に約361億2,000万米ドルと評価され、予測期間の2023年から2030年には4.64%以上の健全な成長率で成長すると予測されています。喘息・COPD治療薬は、喘息や慢性閉塞性肺疾患（COPD）などの呼吸器疾患の管理・治療に使用される薬剤です。喘息とCOPDはともに、気道の炎症・狭窄を特徴とする慢性呼吸器疾患であり、喘鳴、息切れ、咳、胸部圧迫感などの症状を引き起こします。喘息・COPD治療薬市場は、個別化治療の傾向の高まり、ライフスタイルの変化、医療サービスへのアクセス向上と相まって増加する政府支援などの要因により拡大しています。
さらに、喘息とCOPDの有病率の増加が、世界中で市場成長の触媒として作用しています。喘息とCOPDは慢性呼吸器疾患で、世界的に大きな負担となっています。世界保健機関（WHO）によると、呼吸器疾患感染症は年間約300万人（世界の死亡者数の6％）が死亡する第3の主要死因とされています。COPDによる死亡者の90％近くは中低所得国の70歳代で発生しています。また、約2億6,200万人の患者が喘息に苦しんでいると推定され、小児がよく罹患します。このように、大気汚染、喫煙、高齢化、ライフスタイルの変化などの要因により、これらの疾患の有病率が増加していることが、喘息やCOPDを管理・治療するための効果的な薬剤に対する需要の高まりに寄与しており、これが推定期間中の喘息・COPD治療薬市場の成長を促進しています。さらに、薬剤開発における技術的進歩、喘息およびCOPDに関する認識の高まり、診断技術の向上は、予測期間中に様々な有利な機会をもたらします。しかし、薬剤に伴う副作用や製品承認のための厳しい政府規制が、2023年から2030年の予測期間を通じて市場成長の課題となっています。
世界の喘息・COPD治療薬市場調査の対象となる主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、中東・アフリカが含まれます。北アメリカは、研究開発活動の増加、政府および非政府組織による資金提供数の増加により、2022年の市場を独占しました。一方、アジア太平洋地域は予測期間中に最も高いCAGRで成長すると予想されます。医療支出の増加、有利な償還政策、高齢化人口の増加、および有利な償還政策が、この地域全体の市場需要を大幅に促進しています。
この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。
このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Asthma and COPD Drugs Market, by Region, 2020-2030 (USD Billion)
1.2.2. Asthma and COPD Drugs Market, by Diseases, 2020-2030 (USD Billion)
1.2.3. Asthma and COPD Drugs Market, by Medication Class, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Asthma and COPD Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Asthma and COPD Drugs Market Dynamics
3.1. Asthma and COPD Drugs Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of asthma and COPD
3.1.1.2. Rising trend of personalized therapy
3.1.2. Market Challenges
3.1.2.1. Side effects associated with drugs
3.1.2.2. Stringent government regulations for product approvals
3.1.3. Market Opportunities
3.1.3.1. Technological advancements in drug development
3.1.3.2. Increasing awareness about asthma and COPD, along with improved diagnostic techniques
Chapter 4. Global Asthma and COPD Drugs Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Asthma and COPD Drugs Market, by Diseases
5.1. Market Snapshot
5.2. Global Asthma and COPD Drugs Market by Diseases, Performance - Potential Analysis
5.3. Global Asthma and COPD Drugs Market Estimates & Forecasts by Diseases 2020-2030 (USD Billion)
5.4. Asthma and COPD Drugs Market, Sub Segment Analysis
5.4.1. Asthma
5.4.2. COPD
Chapter 6. Global Asthma and COPD Drugs Market, by Medication Class
6.1. Market Snapshot
6.2. Global Asthma and COPD Drugs Market by Medication Class, Performance - Potential Analysis
6.3. Global Asthma and COPD Drugs Market Estimates & Forecasts by Medication Class 2020-2030 (USD Billion)
6.4. Asthma and COPD Drugs Market, Sub Segment Analysis
6.4.1. Combination Drugs
6.4.2. Short Acting Beta Agonists (SABA)
6.4.3. Long Acting Beta Agonists (LABA)
6.4.4. Leukotriene Antagonists (LTA)
6.4.5. Anticholinergics
6.4.6. Others
Chapter 7. Global Asthma and COPD Drugs Market, Regional Analysis
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Asthma and COPD Drugs Market, Regional Market Snapshot
7.4. North America Asthma and COPD Drugs Market
7.4.1. U.S. Asthma and COPD Drugs Market
7.4.1.1. Diseases breakdown estimates & forecasts, 2020-2030
7.4.1.2. Medication Class breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Asthma and COPD Drugs Market
7.5. Europe Asthma and COPD Drugs Market Snapshot
7.5.1. U.K. Asthma and COPD Drugs Market
7.5.2. Germany Asthma and COPD Drugs Market
7.5.3. France Asthma and COPD Drugs Market
7.5.4. Spain Asthma and COPD Drugs Market
7.5.5. Italy Asthma and COPD Drugs Market
7.5.6. Rest of Europe Asthma and COPD Drugs Market
7.6. Asia-Pacific Asthma and COPD Drugs Market Snapshot
7.6.1. China Asthma and COPD Drugs Market
7.6.2. India Asthma and COPD Drugs Market
7.6.3. Japan Asthma and COPD Drugs Market
7.6.4. Australia Asthma and COPD Drugs Market
7.6.5. South Korea Asthma and COPD Drugs Market
7.6.6. Rest of Asia Pacific Asthma and COPD Drugs Market
7.7. Latin America Asthma and COPD Drugs Market Snapshot
7.7.1. Brazil Asthma and COPD Drugs Market
7.7.2. Mexico Asthma and COPD Drugs Market
7.8. Middle East & Africa Asthma and COPD Drugs Market
7.8.1. Saudi Arabia Asthma and COPD Drugs Market
7.8.2. South Africa Asthma and COPD Drugs Market
7.8.3. Rest of Middle East & Africa Asthma and COPD Drugs Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Vectura Group Limited
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summaryd
8.3.1.5. Recent Developments
8.3.2. Abbott Laboratories
8.3.3. Glaxosmithkline Plc
8.3.4. Sanofi
8.3.5. Organon
8.3.6. F. Hoffmann-La Roche AG
8.3.7. Novartis AG
8.3.8. Boehringer Ingelheim International GmbH
8.3.9. Teva Pharmaceutical Industries Ltd
8.3.10. AstraZeneca Plc
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Asthma and COPD Drugs Market, report scope
TABLE 2. Global Asthma and COPD Drugs Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Asthma and COPD Drugs Market estimates & forecasts by Diseases 2020-2030 (USD Billion)
TABLE 4. Global Asthma and COPD Drugs Market estimates & forecasts by Medication Class 2020-2030 (USD Billion)
TABLE 5. Global Asthma and COPD Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Asthma and COPD Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Asthma and COPD Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Asthma and COPD Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Asthma and COPD Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Asthma and COPD Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Asthma and COPD Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Asthma and COPD Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Asthma and COPD Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Asthma and COPD Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Asthma and COPD Drugs Market
TABLE 70. List of primary sources, used in the study of global Asthma and COPD Drugs Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Asthma and COPD Drugs Market, research methodology
FIG 2. Global Asthma and COPD Drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Asthma and COPD Drugs Market, key trends 2022
FIG 5. Global Asthma and COPD Drugs Market, growth prospects 2023-2030
FIG 6. Global Asthma and COPD Drugs Market, porters 5 force model
FIG 7. Global Asthma and COPD Drugs Market, pest analysis
FIG 8. Global Asthma and COPD Drugs Market, value chain analysis
FIG 9. Global Asthma and COPD Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Asthma and COPD Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Asthma and COPD Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Asthma and COPD Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Asthma and COPD Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Asthma and COPD Drugs Market, regional snapshot 2020 & 2030
FIG 15. North America Asthma and COPD Drugs Market 2020 & 2030 (USD Billion)
FIG 16. Europe Asthma and COPD Drugs Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Asthma and COPD Drugs Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Asthma and COPD Drugs Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Asthma and COPD Drugs Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
